The Data Monitoring Committee - Bridging the gap between urology and public health epidemiology

BJU International, Supplement

Volumn 92, Issue 2, 2003, Pages 55-56

  Smith, P H ^a,b  

^a ERSPC   (Netherlands)

^b NONE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CALCULATION; CANCER MORTALITY; CANCER SCREENING; CLINICAL TRIAL; HEALTH CARE ORGANIZATION; HUMAN; MALE; MANAGEMENT; MEDICAL SPECIALIST; PRIORITY JOURNAL; PROFESSIONAL STANDARD; PROSTATE CANCER; PUBLIC HEALTH; REVIEW; SCREENING TEST;

AGED; CLINICAL TRIALS DATA MONITORING COMMITTEES; EPIDEMIOLOGIC METHODS; EUROPE; HUMANS; MALE; MASS SCREENING; MIDDLE AGED; MULTICENTER STUDIES; PROSTATIC NEOPLASMS; PUBLIC HEALTH; RANDOMIZED CONTROLLED TRIALS;

EID: 0346496000     PISSN: 14655101     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (5)

1. Wilson JMG, Jungner G. Principles and Practice of Screening for Disease. Geneva: World Health Organization, 1968
2. Towler B, Irwig L, Glasziou P, Kewenter J, Weller D, Silagy C. A systematic review of the effects of screening for colorectal cancer using the faecal occult blood test, hemoccult. Br Med J 1998; 317: 559
3. Nystrom L, Rutqvist LE, Wall S et al. Breast cancer screening with mammography: overview of Swedish randomised trials. Lancet 1993; 341: 973-8
4. De Koning HJ, Liem MK, Baan CA, Boer R, Schroder FH, Alexander FE. Prostate cancer mortality reduction by screening: power and time frame with complete enrolment in the European Randomised Screening for Prostate Cancer (ERSPC) trial. Int J Cancer 2002; 98: 268-73
5. Bartsch G, Horninger W, Klocker H et al. Prostate cancer mortality after introduction of prostate-specific antigen mass screening in the Federal State of Tyrol, Austria. Urology 2001; 58: 417-24